Literature DB >> 10855259

Semi-invasive and invasive procedures for the diagnosis and staging of lung cancer. I. Percutaneous transthoracic needle biopsy.

D Shaham1.   

Abstract

PTNB is a well-established technique for the diagnosis of lung cancer. In recent years, CT guidance has become the primary imaging modality, replacing fluoroscopy guided biopsies in many institutions. CT fluoroscopy, which is currently not universally available, offers promising advantages and may permit accurate and rapid procedures. A recent innovation in biopsy needles has been the introduction of automatic core biopsy needle devices that yield large specimens and improve the diagnostic accuracy of needle biopsy, particularly in benign lesions. PTNB is one of several methods available for tissue diagnosis of suspected lung cancer. The decision as to which method to use should be tailored to each patient, and is preferably reached by a team consisting of pulmonary physicians, chest surgeons, oncologists, cytologists, and radiologists.

Entities:  

Mesh:

Year:  2000        PMID: 10855259     DOI: 10.1016/s0033-8389(05)70182-2

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  7 in total

1.  Guidelines for radiologically guided lung biopsy.

Authors:  A Manhire; M Charig; C Clelland; F Gleeson; R Miller; H Moss; K Pointon; C Richardson; E Sawicka
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

Review 2.  Common complications of nonvascular percutaneous thoracic interventions: diagnosis and management.

Authors:  Azzam Khankan; Shireen Sirhan; Fadi Aris
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 3.  Pneumothorax after transbronchial needle biopsy.

Authors:  Tatjana Boskovic; Milos Stojanovic; Jelena Stanic; Slobodanka Pena Karan; Gordana Vujasinovic; Dragan Dragisic; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Antonis Papaiwannou; Athanasios Madesis; Konstantinos Diplaris; Theodoros Karaiskos; Bojan Zaric; Perin Branislav; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 4.  The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer.

Authors:  Qinghua Zhou; Jingsi Dong; Jie He; Deruo Liu; David H Tian; Shugeng Gao; Shanqing Li; Lunxu Liu; Jianxing He; Yunchao Huang; Shidong Xu; Weimin Mao; Qunyou Tan; Chun Chen; Xiaofei Li; Zhu Zhang; Gening Jiang; Lin Xu; Lanjun Zhang; Jianhua Fu; Hui Li; Qun Wang; Lijie Tan; Danqing Li; Qinghua Zhou; Xiangning Fu; Zhongmin Jiang; Haiquan Chen; Wentao Fang; Xun Zhang; Yin Li; Ti Tong; Zhentao Yu; Yongyu Liu; Xiuyi Zhi; Tiansheng Yan; Xingyi Zhang; Roberto F Casal; Eugenio Pompeo; Angelo Carretta; Marc Riquet; Ottavio Rena; Pierre-Emmanuel Falcoz; Hisashi Saji; Ali Zamir Khan; Jose Luis Danguilan; Diego Gonzalez-Rivas; Nicolas Guibert; Chengchu Zhu; Jianfei Shen
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 5.  Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance.

Authors:  Tatjana Boskovic; Jelena Stanic; Slobodanka Pena-Karan; Paul Zarogoulidis; Kostas Drevelegas; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Andreas Mpakas; Kosmas Tsakiridis; Georgios Kesisis; Theodora Tsiouda; Ioanna Kougioumtzi; Stamatis Arikas; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 6.  Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer.

Authors:  Henk Kramer; Harry J M Groen
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

Review 7.  Save or sacrifice the internal mammary pedicle during anterior mediastinotomy?

Authors:  Efstratios Apostolakis; Nikolaos A Papakonstantinou; Serafeim Chlapoutakis; Christos Prokakis
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.